A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil
Clinical trial NCT03695094 · COMPLETED
Trial details
- NCT number
- NCT03695094
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-18
- Primary completion
- 2019-05-18
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.